Attenuation of silica-induced pulmonary fibroblasts proliferation by taurine and niacin in vitro

Experimental Lung Research

Volumn 35, Issue 3, 2009, Pages 198-209

  Ji, Wen Jie ^a   Zhou, Xin ^b   Zeng, Shan ^b   Wang, Shi Xin ^c  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^c Dong Li Hospital   (China)

Author keywords

Fibroblast; Macrophage; Niacin; Silicosis; Taurine; Transforming growth factor 1

Indexed keywords

MESSENGER RNA; NICOTINIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; SILICON DIOXIDE; TAURINE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; LUNG INJURY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILICOSIS; SUPERNATANT; SUPPLEMENTATION; UPREGULATION; CELL LINE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FIBROBLAST; GENETICS; LUNG; MONOCYTE; PATHOLOGY;

CELL LINE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FIBROBLASTS; HUMANS; LUNG; MACROPHAGES; MONOCYTES; NIACIN; RNA, MESSENGER; SILICON DIOXIDE; SILICOSIS; TAURINE; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67149141543     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140802499401     Document Type: Article

References (34)

1. Steenland K: One agent, many diseases: exposure-response data and comparative risks of different outcomes following silica exposure. Am J Ind Med. 2005;48:16-23.
2. Delgado L, Parra ER, Capelozzi VL: Apoptosis and extracellular matrix remodelling in human silicosis. Histopathology. 2006;49:283-289.
3. teWaternaude JM, Ehrlich RI, Churchyard GJ, Pemba L, Dekker K, Vermeis M, White NW, Thompson ML, Myers JE: Tuberculosis and silica exposure in South African gold miners. Occup Environ Med. 2006;63:187-192.
4. Lacasse Y, Martin S, Simard S, Desmeules M: Meta-analysis of silicosis and lung cancer. Scand J Work Environ Health. 2005:31:450-458.
5. Weiner J, Barlow L, Sjogren B: Ischemic heart disease mortality among miners and other potentially silica-exposed workers. Am J Ind Med. 2007;50:403-408.
6. Nemmar A, Nemery B, Hoet PH, Van Rooijen N, Hoylaerts MF: Silica particles enhance peripheral thrombosis: key role of lung macrophage-neutrophil cross-talk. Am J Respir Crit Care Med. 2005;171:872-879.
7. Pernis B: Silica and the immune system. Acta Biomed. 2005;76(Suppl 2):38-44.
8. Lahiri S, Levenstein C, Nelson DI, Rosenberg BJ: The cost effectiveness of occupational health interventions: prevention of silicosis. Am J Ind Med. 2005;48:503-514.
9. Jagirdar J, Begin R, Dufresne A, Goswami S, Lee TC, Rom WN: Transforming growth factor-beta (TGF-beta) in silicosis. Am J Respir Crit Care Med. 1996;154:1076-1081.
10. Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, Hori M: Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int. 2000;58:1885-1892.
11. Khalil N, Whitman C, Zuo L, Danielpour D, Greenberg A: Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest. 1993;92:1812-1818.
12. Khalil N, Bereznay O, Sporn M, Greenberg AH: Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med. 1989;170:727-737.
13. Gurujeyalakshmi G, Wang Y, Giri SN: Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice. J Pharmacol Exp Ther. 2000;293:82-90.
14. Giri SN: Novel pharmacological approaches to manage interstitial lung fibrosis in the twenty-first century. Annu Rev Pharmacol Toxicol. 2003;43:73-95.
15. Gurujeyalakshmi G, Hollinger MA, Giri SN: Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis. Am J Respir Cell Mol Biol. 1998;18:334-342.
16. Garner B, Mellor HR, Butters TD, Dwek RA, Platt FM: Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids. Biochem Biophys Res Commun. 2002;290:1361-1367.
17. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A: IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med. 2006;12:99-106.
18. Barbarin V, Arras M, Misson P, Delos M, McGarry B, Phan SH, Lison D, Huaux F: Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am J Respir Cell Mol Biol. 2004;31:78-85.
19. van den Brule S, Misson P, Buhling F, Lison D, Huaux F: Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta. Respir Res. 2005;6:84.
20. Razzaque MS, Taguchi T: Pulmonary fibrosis: Cellular and molecular events. Pathol Int. 2003;53:133-145.
21. Huxtable RJ: Physiological actions of taurine. Physiol Rev. 1992;72:101-163.
22. Xu YJ, Saini HK, Zhang M, Elimban V, Dhalla NS: MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine. Cardiovasc Res. 2006;72:163-174.
23. Franconi F, Loizzo A, Ghirlanda G, Seghieri G: Taurine supplementation and diabetes mellitus. Curr Opin Clin Nutr Metab Care. 2006;9:32-36.
24. Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, Sole MJ, Backx PH: Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation. 2004;109:1877-1885.
25. Liu H, Zhang H, Forman HJ: Silica induces macrophage cytokines through phosphatidylcholine-specific phospholipase C with hydrogen peroxide. Am J Respir Cell Mol Biol. 2007;36:594-599.
26. Ke Q, Li J, Ding J, Ding M, Wang L, Liu B, Costa M, Huang C: Essential role of ROS-mediated NFAT activation in TNF-alpha induction by crystalline silica exposure. Am J Physiol Lung Cell Mol Physiol. 2006;291:L257-L264.
27. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS: The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A. 2008;105:9035-9040.
28. Sato T, Takeno M, Honma K, Yamauchi H, Saito Y, Sasaki T, Morikubo H, Nagashima Y, Takagi S, Yamanaka K, Kaneko T, Ishigatsubo Y: Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med. 2006;174:906-914.
29. Goldstein S, Czapski G, Heller A: Mode of action of poly(vinylpyridine- N-oxide) in preventing silicosis: effective scavenging of carbonate anion radical. Chem Res Toxicol. 2006;19:86-91.
30. + metabolism in health and disease. Trends Biochem Sci. 2007;32:12-19.
31. Wang SX, Du HK, Zhang HZ, Cai SX, Fan HQ, Wang CE: Effects of niacin on nitric oxide synthase expression in rat lungs exposed to silica. Prog Natl Sci. 2004;14:1069-1073.
32. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN: Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-alpha-induced oxidant stress. Am J Physiol. 1999;276:L979-L988.
33. Thannickal VJ, Fanburg BL: Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1005-L1028.
34. Fubini B, Hubbard A: Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med. 2003;34:1507-1516.